APLS
Apellis Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$18.94
+0.55 ▲ +2.99%
🌙 3월 13일 6:08 PM ET (한국 3/14 07:08)
$19.23
+0.29 ▲ +1.53%
| Index | - | P/E | 153.36 | EPS (ttm) | 0.12 | Insider Own | 18.3% | Shs Outstand | 0.13B | Perf Week | -5.63% |
| Market Cap | 2.42B | Forward P/E | - | EPS next Y | 85.91% | Insider Trans | -1.02% | Shs Float | 0.10B | Perf Month | -15.11% |
| Enterprise Value | 2.43B | PEG | - | EPS next Q | -0.35 | Inst Own | 95.87% | Short Float | 21.96% | Perf Quarter | -23.26% |
| Income | 0.02B | P/S | 2.41 | EPS this Y | -646.86% | Inst Trans | 1.04% | Short Ratio | 8.25 | Perf Half Y | -25.43% |
| Sales | 1.00B | P/B | 6.48 | EPS next 5Y | 83.31% | ROA | 2.28% | Short Interest | 22.93M | Perf YTD | -24.6% |
| Book/sh | 2.92 | P/C | 5.18 | EPS past 3/5Y | - | ROE | 7.48% | 52W High | -37.86% ($30.48) | Perf Year | -22.28% |
| Cash/sh | 3.66 | P/FCF | 53.79 | Sales past 3/5Y | 136.98% 31.98% | ROIC | 3.01% | 52W Low | 17.64% ($16.10) | Perf 3Y | -69.77% |
| Dividend Est. | - | EV/EBITDA | 42.61 | EPS Y/Y TTM | 110.72% | Gross Margin | 89.69% | Volatility(W/M) | 3.75% 4.44% | Perf 5Y | -59.41% |
| Dividend TTM | - | EV/Sales | 2.42 | Sales Y/Y TTM | 28.46% | Oper. Margin | 5.52% | ATR (14) | 0.96 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.7 | EPS Q/Q | -59.44% | Profit Margin | 2.23% | RSI (14) | 33.18 | Recom | 1.87 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.14 | Sales Q/Q | -5.94% | SMA20 | -9.04% ($20.82) | Beta | 0.33 | Target Price | $33.6 |
| Payout | - | Debt/Eq | 1.28 | Earnings | 2000000 | SMA50 | -14.25% ($22.09) | Rel Volume | 0.62 | Prev Close | $18.39 |
| Employees | 739 | LT Debt/Eq | 1.01 | EPS/Sales Surpr. | -25.67% 0.26% | SMA200 | -15.73% ($22.48) | Avg Volume(3M) | 2.78M | Price | $18.94 |
| IPO | 2017/11/9 | Option/Short | Yes/Yes | Trades | 16191 | Volume | 1,716,893 | Change | 2.99% |
뉴스 로딩 중...